Pediatric Diabetic Ketoacidosis (DKA) Differential Diagnoses

1. McGregor S, Metzger DL, Amed S, Goldman RD. Fluid management in children with diabetic ketoacidosis. Can Fam Physician. 2020 Nov. 66 (11):817-9. [QxMD MEDLINE Link]. [Full Text].

2. Edge JA, Roy Y, Bergomi A, et al. Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration. Pediatr Diabetes. 2006 Feb. 7(1):11-5. [QxMD MEDLINE Link].

3. Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med. 1994 Oct. 148(10):1046-52. [QxMD MEDLINE Link].

4. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis. Pediatr Diabetes. 2007 Feb. 8(1):28-43. [QxMD MEDLINE Link].

5. Marshall SM, Walker M, Alberti KGMM. Diabetic Ketoacidosis and Hyperglycaemic non-ketotic coma. Alberti, Zimmet, Defronzo eds. International Textbook of Diabetes Mellitus. 1997. 1215-30.

6. Fagan MJ, Avner J, Khine H. Initial fluid resuscitation for patients with diabetic ketoacidosis: how dry are they?. Clin Pediatr (Phila). 2008 Nov. 47(9):851-5. [QxMD MEDLINE Link].

7. Durr JA, Hoffman WH, Sklar AH, et al. Correlates of brain edema in uncontrolled IDDM. Diabetes. 1992 May. 41(5):627-32. [QxMD MEDLINE Link].

8. Hale PM, Rezvani I, Braunstein AW, et al. Factors predicting cerebral edema in young children with diabetic ketoacidosis and new onset type I diabetes. Acta Paediatr. 1997 Jun. 86(6):626-31. [QxMD MEDLINE Link].

9. Mel JM, Werther GA. Incidence and outcome of diabetic cerebral oedema in childhood: are there predictors?. J Paediatr Child Health. 1995 Feb. 31(1):17-20. [QxMD MEDLINE Link].

10. Silver SM, Clark EC, Schroeder BM, Sterns RH. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis [published erratum appears in Kidney Int 1997 May;51(5):1662]. Kidney Int. 1997 Apr. 51(4):1237-44. [QxMD MEDLINE Link].

11. Okuda Y, Adrogue HJ, Field JB, et al. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996 Jan. 81(1):314-20. [QxMD MEDLINE Link].

12. Azova S, Rapaport R, Wolfsdorf J. Brain injury in children with diabetic ketoacidosis: review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. Pediatr Diabetes. 2020 Nov 16. [QxMD MEDLINE Link].

13. Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved?. Pediatr Diabetes. 2009 Dec. 10(8):534-41. [QxMD MEDLINE Link].

14. Musey VC, Lee JK, Crawford R. Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995 Apr. 18(4):483-9. [QxMD MEDLINE Link].

15. Thompson CJ, Cummings F, Chalmers J, Newton RW. Abnormal insulin treatment behaviour: a major cause of ketoacidosis in the young adult. Diabet Med. 1995 May. 12(5):429-32. [QxMD MEDLINE Link].

16. Morris AD, Boyle DI, McMahon AD, et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997 Nov 22. 350(9090):1505-10. [QxMD MEDLINE Link].

17. Smaldone A, Honig J, Stone PW, et al. Characteristics of California children with single versus multiple diabetic ketoacidosis hospitalizations (1998-2000). Diabetes Care. 2005 Aug. 28(8):2082-4. [QxMD MEDLINE Link]. [Full Text].

18. Holstein A, Abel C, Zumwalde I. Recurrent severe diabetic ketoacidosis due to intoxication with synthetic drugs ('Ecstasy' and 'Speed'). Intensivmedizin und Notfallmedizin. 1997. 34(1):46-50.

19. Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics. 2008 May. 121(5):e1258-66. [QxMD MEDLINE Link].

20. Smith CP, Firth D, Bennett S, et al. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr. 1998 May. 87(5):537-41. [QxMD MEDLINE Link].

21. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002 May 15. 287(19):2511-8. [QxMD MEDLINE Link].

22. Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001 Oct. 44 Suppl 3:B75-80. [QxMD MEDLINE Link].

23. Edge JA, Dunger DB. Variations in the management of diabetic ketoacidosis in children. Diabet Med. 1994 Dec. 11(10):984-6. [QxMD MEDLINE Link].

24. Neu A, Hofer SE, Karges B, Oeverink R, Rosenbauer J, Holl RW. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care. 2009 Sep. 32(9):1647-8. [QxMD MEDLINE Link]. [Full Text].

25. Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011 Jul 7. 343:d4092. [QxMD MEDLINE Link].

26. Fritsch M, Rosenbauer J, Schober E, Neu A, Placzek K, Holl RW. Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes. 2011 Jun. 12(4 Pt 1):307-12. [QxMD MEDLINE Link].

27. Delamater AM, Shaw KH, Applegate EB, et al. Risk for metabolic control problems in minority youth with diabetes. Diabetes Care. 1999 May. 22(5):700-5. [QxMD MEDLINE Link]. [Full Text].

28. Cohn BA, Cirillo PM, Wingard DL, et al. Gender differences in hospitalizations for IDDM among adolescents in California, 1991. Implications for prevention. Diabetes Care. 1997 Nov. 20(11):1677-82. [QxMD MEDLINE Link].

29. Quinn M, Fleischman A, Rosner B, et al. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006 Mar. 148(3):366-71. [QxMD MEDLINE Link].

30. Ghetti S, Lee JK, Sims CE, Demaster DM, Glaser NS. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr. 2010 Jan. 156(1):109-14. [QxMD MEDLINE Link].

31. Edge JA, Ford-Adams ME, Dunger DB, et al. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999 Oct. 81(4):318-23. [QxMD MEDLINE Link]. [Full Text].

32. Neu A, Willasch A, Ehehalt S, et al. Ketoacidosis at onset of type 1 diabetes mellitus in children--frequency and clinical presentation. Pediatr Diabetes. 2003 Jun. 4(2):77-81. [QxMD MEDLINE Link].

33. Warner DP, McKinney PA, Law GR, Bodansky HJ. Mortality and diabetes from a population based register in Yorkshire 1978-93. Arch Dis Child. 1998 May. 78(5):435-8. [QxMD MEDLINE Link]. [Full Text].

34. Hoffman WH, Locksmith JP, Burton EM, et al. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications. 1998 Nov-Dec. 12(6):314-20. [QxMD MEDLINE Link].

35. Holsclaw DS Jr, Torcato B. Acute pulmonary edema in juvenile diabetic ketoacidosis. Pediatr Pulmonol. 1997 Dec. 24(6):438-43. [QxMD MEDLINE Link].

36. Yang EM, Lee HG, Oh KY, Kim CJ. Acute kidney injury in pediatric diabetic ketoacidosis. Indian J Pediatr. 2020 Nov 19. [QxMD MEDLINE Link].

37. Myers SR, Glaser NS, Trainor JL, et al, Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group. Frequency and risk factors of acute kidney injury during diabetic ketoacidosis in children and association with neurocognitive outcomes. JAMA Netw Open. 2020 Dec 1. 3 (12):e2025481. [QxMD MEDLINE Link]. [Full Text].

38. Wei Y, Wu C, Su F, Zhang H, Zhang J, Zheng R. Clinical characteristics and outcomes of patients with diabetic ketoacidosis of different severity. Medicine (Baltimore). 2020 Nov 6. 99 (45):e22838. [QxMD MEDLINE Link]. [Full Text].

39. Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004 Jul. 27(7):1541-6. [QxMD MEDLINE Link].

40. Sottosanti M, Morrison GC, Singh RN, Sharma AP, Fraser DD, Alawi K, et al. Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child. 2012 Feb. 97(2):96-100. [QxMD MEDLINE Link].

41. Brandenburg MA, Dire DJ. Comparison of arterial and venous blood gas values in the initial emergency department evaluation of patients with diabetic ketoacidosis. Ann Emerg Med. 1998 Apr. 31(4):459-65. [QxMD MEDLINE Link].

42. Wiggam MI, O'Kane MJ, Harper R, et al. Treatment of diabetic ketoacidosis using normalization of blood 3- hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care. 1997 Sep. 20(9):1347-52. [QxMD MEDLINE Link].

43. Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007 Jun. 8(3):150-6. [QxMD MEDLINE Link].

44. Fiordalisi I, Novotny WE, Holbert D, Finberg L, Harris GD. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes. 2007 Jun. 8(3):142-9. [QxMD MEDLINE Link].

45. Puttha R, Cooke D, Subbarayan A, Odeka E, Ariyawansa I, Bone M. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes. 2009 Jul 6. [QxMD MEDLINE Link].

46. Butkiewicz EK, Leibson CL, O'Brien PC, Palumbo PJ, Rizza RA. Insulin therapy for diabetic ketoacidosis. Bolus insulin injection versus continuous insulin infusion. Diabetes Care. 1995 Aug. 18(8):1187-90. [QxMD MEDLINE Link].

47. Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005 Aug. 28(8):1856-61. [QxMD MEDLINE Link].

48. Green SM, Rothrock SG, Ho JD, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998 Jan. 31(1):41-8. [QxMD MEDLINE Link].

49. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed). 1984 Oct 20. 289(6451):1035-8. [QxMD MEDLINE Link].

50. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006 Jun. 102(6):1836-46. [QxMD MEDLINE Link].

51. Vanelli M, Chiari G, Ghizzoni L, et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999 Jan. 22(1):7-9. [QxMD MEDLINE Link]. [Full Text].

52. [Guideline] Miller SG. Family therapy for recurrent diabetic ketoacidosis: Treatment guidelines. Family Systems Medicine. 1996. 14(3):303-14.

53. Douglas D. Isotonic Fluids Helpful in Diabetic Ketoacidosis in Kids: Study. Medscape. Apr 4 2013. Available at http://www.medscape.com/viewarticle/781938. Accessed: April 16, 2013.

54. White PC, Dickson BA. Low Morbidity and Mortality in Children with Diabetic Ketoacidosis Treated with Isotonic Fluids. J Pediatr. 2013 Mar 15. [QxMD MEDLINE Link].

William H Lamb, MD, MBBS, FRCP(Edin), FRCP, FRCPCH Consultant Paediatric Diabetologist, Bishop Auckland General Hospital, County Durham and Darlington NHS Foundation Trust, UK

William H Lamb, MD, MBBS, FRCP(Edin), FRCP, FRCPCH is a member of the following medical societies: British Medical Association, International Society for Pediatric and Adolescent Diabetes, Royal College of Paediatrics and Child Health, Royal College of Physicians

Disclosure: Nothing to disclose.

Dale W Steele, MD, MS Professor of Emergency Medicine, Pediatrics, and Health Services, Policy, and Practice, Warren Alpert Medical School of Brown University; Attending Physician, Department of Pediatric Emergency Medicine, Rhode Island Hospital

Dale W Steele, MD, MS is a member of the following medical societies: American Academy of Pediatrics, American Statistical Association, Society for Medical Decision Making

Disclosure: Nothing to disclose.

Timothy E Corden, MD Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, Wisconsin Medical Society

Disclosure: Nothing to disclose.

G Patricia Cantwell, MD, FCCM Professor of Clinical Pediatrics, Chief, Division of Pediatric Critical Care Medicine, University of Miami, Leonard M Miller School of Medicine; Medical Director, Palliative Care Team, Director, Pediatric Critical Care Transport, Holtz Children's Hospital, Jackson Memorial Medical Center; Medical Manager, FEMA, Urban Search and Rescue, South Florida, Task Force 2; Pediatric Medical Director, Tilli Kids – Pediatric Initiative, Division of Hospice Care Southeast Florida, Inc

G Patricia Cantwell, MD, FCCM is a member of the following medical societies: American Academy of Hospice and Palliative Medicine, American Academy of Pediatrics, American Heart Association, American Trauma Society, National Association of EMS Physicians, Society of Critical Care Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Barry J Evans, MD Assistant Professor of Pediatrics, Temple University Medical School; Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center

Barry J Evans, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Acknowledgments

The author would like to thank Debbie Matthews and Tim Cheetham for reading the manuscript and for all of their support.

• Print this section
• Print the entire contents of
• Print the entire contents of article